Unlock Strategic Intelligence with Fundz

Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.

Two more pharmas practice their Accent, invest in $75M series C round

01/23/24, 11:06 AM

Location

lexington

Money raised

$75 million

Industry

biotechnology

Investors

Mirae Asset Capital Life Science, Johnson & Johnson, Bristol Myers Squibb

Accent Therapeutics raised $75 million in a series C round, with investments from Bristol Myers Squibb and Johnson & Johnson’s investment arm, JJDC, led by Mirae Asset Capital Life Science. The funding will drive further development of the company’s lead small molecules and advance them into human trials.

🔒 Strategic shifts and deeper insights are available for this company. Unlock full access to view hidden updates, executive moves, and more.

Company Info

Company

Accent Therapeutics

Location

lexington, massachusetts, united states

Additional Info

Accent is leading the translation of RNA-modifying protein (RMP) biology into promising new therapies by combining a robust chemical biology platform with rigorous approaches to target identification and validation. Our seasoned team of drug developers is uniquely experienced to interrogate and advance small molecule therapies with far-reaching potential.

Unlock Strategic Intelligence with Fundz

Access real-time funding updates, strategic shifts with FundzWatch™, exclusive Family Offices, and more — helping you close deals and seize opportunities faster.

Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.

Related people

Trends

	Raised	Growth The data in the raised column shows reported funding for this location/industry over last 90 days. The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days. Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage.
lexington	$24.7 M	-61.4%